Resistencia de bacterias respiratorias y entéricas a antibióticos

Salud Publica de Mexico

Volumn 40, Issue 6, 1998, Pages 510-516

  Solórzano Santos, Fortino ^a   Miranda Novales, Ma Guadalupe ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CHLORAMPHENICOL DERIVATIVE; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; INTESTINE INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SHIGELLA; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; VIBRIO CHOLERAE;

ADULT; AMPICILLIN; AMPICILLIN RESISTANCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CAMPYLOBACTER JEJUNI; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INTESTINES; PENICILLIN RESISTANCE; PENICILLINS; RESPIRATORY SYSTEM; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SHIGELLA; SHIGELLA DYSENTERIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VIBRIO CHOLERAE;

EID: 0032443114     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-36341998000600008     Document Type: Article

References (44)

1. Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: A strategic priority for hospitals worldwide. Clin Infect Dis 1997:24 Suppl 1:S139-S145.
2. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-1311.
3. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L et al. The population of genetics of antibiotic resistance. Clin Infect Dis 1997;24 suppl 1:S9-S16.
4. Kaplan EL. Benzathine penicillin G for treatment of group A streptococal pharyngitis:A reppraisal in 1985. Pediatr Infect Dis J 1985;4:592-596.
5. Gutmann L, Tomaz A. Penicillin-resistant and penicillin-mutants of group A streptococci. Antimicrob Agents Chemother 1982;2:128-136.
6. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J 1994;13:630-635.
7. Breiman RF, Spika JS, Navarro VJ, Darden PM, Dasby CP. Pneumococcal bacteremia in Charleston County, South Carolina: A decade later. Arch Intern Med 1990;150:1401-1405.
8. Sistema Nacional de Evaluación. Tercera Vigilancia de los Progresos en ia Aplicación de Estrategias de Salud para Todos en el año 2000, SPT/ 2000. México, D.F.: INEGI/DGEIE, 1994.
9. Zighelboim S, Tomaz A. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1980;17:434-442.
10. Soares S, Kristinsson KG, Musser JM, Tomaz A Evidence for the introduction of a multiresistant clone of serotype 6b Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993;168:158-163.
11. Muñoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302-306.
12. Guiscafré GH, García MM, Trejp PJA, García M, Hernandez VR, Muñoz HO. Frecuencia de Haemophilus influenzae y de Streptococcus pneumoniae resistente a penicilina en portadores sanos. Arch Invest Med Mex 1981; 12:141-151.
13. Calderón JE, Echaniz AG, Conde GC, Rivera SR, Barriga AG, Solórzano SF et al. Resistencia y serotipificación de 83 cepas de Streptococcus pneumoniae aisladas de niños portadores asintomáticos y enfermos. Bol Med Hosp Infant Mex 1993;50:854-860.
14. Echaniz AG, Velázquez MM, Carnalla BMN, Soto NA Solórzano SF, Gatica MR et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City. Microb Drug Resist 1997;3:153-157.
15. Low DE, Azavedo J, McGeer A. El impacto de los neumococos resistentes a penicilina en la práctica clinica. Enferm Infecc Microbiol Clin 1998;18:137-140.
16. Moxon RE. The carrier state: Haemophilus influenzae. J Antimicrob Chemother 1986;18:17-24.
17. Miranda NMG, Solórzano SF, Velázquez AR, Leaños MB, Villasis KMA, Guiscafré GH. Características de los aislamientos de Haemophilus influenzae de portadores asintomáticos en edad pediátrica y su relación con resistencia a antimicrobianos. Bol Med Hosp Infant Mex 1995;52:148-153.
18. Anianson G, Alm B, Andersson B, Larsson P, Nylen O, Peterson H et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 1992;165 supl 1:38-42.
19. Villaseñor SA, Avila FC, Santos PJI. Impacto de las infecciones por Haemophilus influenzae en niños mexicanos. Bol Med Hosp Infant Mex 1993;50:415-421.
20. Doern G, Jorgensen J, Thornsberry C, Preston DP, Tubert T, Redding JS et al. National colaborative study of prevalence of antimicrobial resistance among clinical isolates of Hoemophilus influenzae. Antimicrob Agents Chemother 1988;32:180-185.
21. Campos J, García TS, Sanfeliu S. Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob Agents Chemother 1984;25:706-709.
22. Jorgensen J. Update on mechanism and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992;14:1119-1123.
23. Scott GM, Thompson R, Rebec MP, Kibbler CC, Smith MD, Holton J. Outbreaks of multirresistant Haemophilus influenzae infection. Lancet 1990;1:925.
24. Campos J, Garcia TS, Gairi JM, Fábregues Y. Multiply resistance Haemophilus influenzae type b causing meningitis: Comparative clinical and laboratory study. J Pediatr 1986;108:897-902.
25. Trejo y Perez JA Guistafré GH, García M, Jaime CM, González S, Muñoz O. Sensibilidad de Haemophilus influenzae a ampicilina o cloranfenicol en niños de la ciudad de México. Bol Med Hosp Infant Mex 1981;38: 79-85.
26. Guiscafré H, Solórzano SF, Delgado O, Muñoz O. Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol Arch Dis Child 1986;61:691-707.
27. Weinberg GA, Spitzer ED, Murray PR. Antimicrobial susceptibility patterns of Hoemophilus isolates from children in eleven developing nations. Bull World Health Organ 1990;68:179-184.
28. Sack RB, Rahman M, Yunus M, Khan EH. Antimicrobial resistance in organisms causing diahrreal disease. Clin Infect Dis 1997;24 suppl 1: S102-S105.
29. Holmberg SD, Solomon SL, Blake PA Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065-1078.
30. Lupski JR. Molecular mechanisms for transposition of drug-resistance genes and other movable genetic elements. Rev Infect Dis 1987; 9:357-368.
31. Mayer KH, Opal SM, Medeiros AA. Mechanisms of antibiotic resistance. En: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. 4a. edición. Nueva York: Churchill Livinsgtone, 1995: 212-224.
32. Bennish ML, Wojtyniak BJ. Mortality due to shigellosis: Community and hospital data. Rev Infect Dis 1991;13:S245-S249.
33. Bennish ML, Salam MA, Hossain MA, Myaux J, Khau EH, Chakrabaty J et al. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole and nalidixic acid. Clin Infect Dis 1992;14: 1055-1060.
34. González-Cortés A Heredia-Duarte A, Guzmán J, Ruiz G, Hernández Arreourtua H. Epidemia de tifoidea por cepas cloranfenicol resistentes en México en 1972. Estudios de transmisión y vigilancia. Salud Publica Mex 1974:34:37-39.
35. Solórzano SF, Leaños MB, Guiscafré GH. Resistencia antimicrobiana actual de Salmonella typhi, Salmonella enteritidis y Shigella sp. Bol Med Hosp Infant Mex 1987;44:448-455.
36. Kumate J, Sepúlveda J, Gutiérrez G. El cólera. Epidemias, endemias y pandemias. México, D.F.: Nueva Editorial Interamericana, 1993.
37. Levine MM. Escherichia coli that cause diarrheae: Enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic and enteroadherent. J Infec Dis 1987;155:377-389.
38. Santos JI, De la Maza L, Tanaka J. Antimicrobial susceptibility of selected bacterial enteropathogens in Latin America and Worldwide. Scand J Gastroenterol 1989;24 suppl 169:28-33.
39. Camorlinga-Ponce M, Gamboa M, Barragan JJ, Muñoz O, Fekety FR, Torres JF. Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrhoeal disease. Eur J Clin Microbiol Infect Dis 1987;6:542-544.
40. Dworczynski A, Sokol B, Meisel-Mikolajczyk F. Antibiotic resistance of Clostridium difficile isolates. Cytobios 1991;65:149-153.
41. Riley IW, Finch MJ. Results of the first year of national surveillance of Campylobacter infections in the United States. J Infect Dis 1985;147: 243-245.
42. Salazar-Lindo E, Sack RB, Chea-Woo E, Kay BA Piscoya ZA, León-Barva P et al. Early treatment with erythromycin of Campylobacter jejuni associated dysentery in children. J Pediatr 1986;109:355-360.
43. Threlfall EJ, Rowe B, Ward LR. A comparison of multiple drug resistance in salmonellas from humans and food animals in England and Wales, 1981 and 1990. Epidemiol Infect 1993;11:189-197.
44. Glynn KM, Bopp C, Dewitt W, Dabney P, Mokhatar M, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DTI04 infections in the United States. N Engl J Med 1998;338: 1333-1338.